Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 6 | $497,074 |
Sells | 10 | $571,172 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
07 Mar 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | MAZZARIELLO GINA | Chief Legal Officer | 05 Mar 2024 | Sale | 1,540 | 18.7279 | 28,841 | D |
07 Mar 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 05 Mar 2024 | Sale | 1,792 | 18.7279 | 33,560 | D |
07 Mar 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | KLEE JUSTIN B. | Co-Chief Executive Officer | 05 Mar 2024 | Sale | 4,135 | 18.7279 | 77,440 | D |
07 Mar 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | COHEN JOSHUA B | Co-Chief Executive Officer | 05 Mar 2024 | Sale | 4,135 | 18.7279 | 77,440 | D |
27 Feb 2024 17:59 | AMLX | Amylyx Pharmaceuticals Inc | MAZZARIELLO GINA | Chief Legal Officer | 23 Feb 2024 | Sale | 2,838 | 18.7564 | 53,231 | D |
11 Jan 2024 17:10 | AMLX | Amylyx Pharmaceuticals Inc | COHEN JOSHUA B | Co-Chief Executive Officer | 09 Jan 2024 | Sale | 5,841 | 16.3281 | 95,372 | D |
11 Jan 2024 17:11 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 09 Jan 2024 | Sale | 2,716 | 16.3281 | 44,347 | D |
11 Jan 2024 17:11 | AMLX | Amylyx Pharmaceuticals Inc | KLEE JUSTIN B. | Co-Chief Executive Officer | 09 Jan 2024 | Sale | 5,841 | 16.3281 | 95,372 | D |
11 Jan 2024 17:04 | AMLX | Amylyx Pharmaceuticals Inc | YERAMIAN PATRICK D | Chief Medical Officer | 09 Jan 2024 | Sale | 2,812 | 16.3281 | 45,915 | D |
19 Dec 2023 16:37 | AMLX | Amylyx Pharmaceuticals Inc | FIRESTONE KAREN | Director | 15 Dec 2023 | Purchase | 4,000 | 14.97 | 59,880 | D |
16 Sep 2024 17:30 | AMLX | Amylyx Pharmaceuticals Inc | FRATES JAMES M | Chief Financial Officer | 12 Sep 2024 | Purchase | 40,000 | 2.5342 | 101,368 | D |
09 Sep 2024 16:05 | AMLX | Amylyx Pharmaceuticals Inc | FIRESTONE KAREN | Director | 05 Sep 2024 | Purchase | 50,000 | 2.1318 | 106,590 | D |
05 Sep 2024 19:26 | AMLX | Amylyx Pharmaceuticals Inc | MILNE GEORGE M JR | Director | 03 Sep 2024 | Purchase | 100,000 | 2.198 | 219,800 | D |
16 May 2024 19:36 | AMLX | Amylyx Pharmaceuticals Inc | MAZZARIELLO GINA | Chief Legal Officer | 15 May 2024 | Sale | 10,455 | 1.8799 | 19,654 | D |
16 May 2024 19:37 | AMLX | Amylyx Pharmaceuticals Inc | QUIMI DAPHNE | Director | 15 May 2024 | Purchase | 2,250 | 1.8899 | 4,252 | D |
16 May 2024 19:37 | AMLX | Amylyx Pharmaceuticals Inc | QUIMI DAPHNE | Director | 14 May 2024 | Purchase | 2,750 | 1.885 | 5,184 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)